Format

Send to

Choose Destination
JAMA. 2016 Oct 18;316(15):1541-1542. doi: 10.1001/jama.2016.12770.

Time to Reassess the Cancer Compendia for Off-label Drug Coverage in Oncology.

Author information

1
Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.
2
Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill2Associate Editor, JAMA.
PMID:
27561002
DOI:
10.1001/jama.2016.12770
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center